Symbiotec Pharmalab Ltd PE Ratio

Symbiotec Pharmalab PE Ratio

Image

Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC

PE

-

Last updated on: Sep 01, 2026

Key Highlights

  • The P/E Ratio of Symbiotec Pharmalab Ltd is 0 as of 01 Sep 15:30 PM The P/E Ratio of Symbiotec Pharmalab Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Latest Trading Price of Symbiotec Pharmalab Ltd is ₹ 1095 as of 01 Sep 16:01 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.4 in 5 years. This represents a CAGR of 5.66% The PE Ratio of Automobile industry is 12.5. The PE Ratio of Finance industry is 16.3. The PE Ratio of IT - Software industry is 18.5. The PE Ratio of Pharmaceuticals industry is 32.1. The PE Ratio of Retail industry is 90.2. The PE Ratio of Textiles industry is 36.8 in 2026 .

Historical P/E Ratio of Symbiotec Pharmalab Ltd

No data available

Company Fundamentals for Symbiotec Pharmalab Ltd

Image

Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC

Share Price

₹ 1095.95

107.95 (10.93%)

stock direction

Last updated on: Sep 01, 2026

Market Price of Symbiotec Pharmalab Ltd

1M

1Y

3Y

5Y

Monitoring Symbiotec Pharmalab Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

SWOT Analysis Of Symbiotec Pharmalab Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Symbiotec Pharmalab Ltd

Asset Value vs Market Value of Symbiotec Pharmalab Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Symbiotec Pharmalab Ltd0
Sun Pharmaceutical Industries Ltd469310
Divis Laboratories Ltd245426
Torrent Pharmaceuticals Ltd189347
Zydus Lifesciences Ltd115920
Cipla Ltd114393

PE Ratio of Symbiotec Pharmalab Ltd Explained

0

Market cap

29

Earnings

0.0X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Symbiotec Pharmalab Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Symbiotec Pharmalab Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Symbiotec Pharmalab Ltd

No data available

* All values are in %

About Symbiotec Pharmalab Ltd

  • Symbiotec Pharmalab Private Limited was incorporated as a private limited company, dated September 20, 2002, with the Registrar of Companies, Madhya Pradesh and Chhattisgarh.
  • Subsequently, the name of the Company was changed to Symbiotec Pharmalab Limited and a fresh certificate of incorporation dated September 26, 2025, was issued by the Central Processing Centre. Symbiotec is one of the few companies globally and only Indian manufacturer having continuous manufacturing for progesterone API manufacturing.
  • The Company has its flow chemistry capability being utilized for progesterone in a new block in Pithampur facility.
  • It is presently engaged in manufacturing and selling of Active Pharmaceuticals Ingredients (API) and Intermediates. The Company has a global leadership position in corticosteroid and steroidal-hormone active pharmaceutical ingredients.

Symbiotec Pharmalab Ltd News Hub

Symbiotec Pharmalab IPO ends with 71.26 times subcription

The initial public offer of Symbiotec Pharmalab received bids for 93,52,49,700 shares as against 1,3

Read more

28 Aug 26

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of null

What is the current PE Ratio of Symbiotec Pharmalab Ltd?

The Current PE Ratio of Symbiotec Pharmalab Ltd is 0.0 as on 1 Sep 2026.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 32.1 as on 1 Sep 2026.

What was the PE Ratio of Symbiotec Pharmalab Ltd last year?

The PE Ratio of Symbiotec Pharmalab Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Symbiotec Pharmalab Ltd indicate about its stock?

The PE Ratio of Symbiotec Pharmalab Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Symbiotec Pharmalab Ltd.

What is the PE Ratio Growth of Symbiotec Pharmalab Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Symbiotec Pharmalab Ltd grew by -% whereas, the EPS ratio grew by -.

How does the PE ratio of Symbiotec Pharmalab Ltd compare to industry peers?

The PE ratio of Symbiotec Pharmalab Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Symbiotec Pharmalab Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Symbiotec Pharmalab Ltd PE Ratio.

What factors influence the PE ratio of Symbiotec Pharmalab Ltd PE Ratio?

The PE ratio of Symbiotec Pharmalab Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Symbiotec Pharmalab Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Symbiotec Pharmalab Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Symbiotec Pharmalab Ltd PE Ratio?

You can check the latest PE ratio of Symbiotec Pharmalab Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Symbiotec Pharmalab Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Symbiotec Pharmalab Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Symbiotec Pharmalab Ltd PE Ratio predict future stock performance?

While the Symbiotec Pharmalab Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions